The Pharmacology of a New Nitric Oxide Donor: B-NOD
- 28 August 2000
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 275 (2) , 350-353
- https://doi.org/10.1006/bbrc.2000.3304
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- New look at myocardial infarction: toward a better aspirinCardiovascular Research, 1999
- Nitric Oxide Donors Induce Late Preconditioning Against Myocardial Stunning and Infarction in Conscious Rabbits via an Antioxidant-Sensitive MechanismCirculation Research, 1998
- Clinical Pharmacokinetics of MolsidomineClinical Pharmacokinetics, 1996
- Differential Hemodynamic Effects of the Nitric Oxide Donor Pirsidomine in Comparison to SIN-1, Nitroprusside and NitroglycerinPharmacology, 1996
- Mechanisms of action of nitratesCardiovascular Drugs and Therapy, 1994
- The nitrovasodilators. New ideas about old drugs.Circulation, 1993
- A simplified method for the determination of nitric oxide in biological solutionsLife Sciences, 1992
- Nitric oxide generation from nitroprusside by vascular tissueBiochemical Pharmacology, 1991
- The Biochemical Pathways of Nitric Oxide Formation from NitrovasodilatorsJournal of Cardiovascular Pharmacology, 1991
- An improved method for washing of human platelets with prostacyclinThrombosis Research, 1983